SCHEMBL17629928

SCHEMBL17629928

N#Cc1cccc(C(=O)O)c1B(O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.40
ALOX15 P16050 1/20 0.40
NOTUM Q6P988 1/20 0.40
HTT P42858 1/20 0.38
LMNA P02545 1/20 0.37
POLB P06746 1/20 0.37
TAS2R14 Q9NYV8 2/20 0.37
XDH P47989 1/20 0.36
SLC22A12 Q96S37 1/20 0.36
TSHR P16473 1/20 0.36
NR4A1 P22736 1/20 0.36
NR4A2 P43354 1/20 0.36
NR4A3 Q92570 1/20 0.36
KDM4E B2RXH2 2/20 0.36
GAA P10253 1/20 0.36
CXCR2 P25025 1/20 0.36
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
HMGB1 P09429 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5784673 0.80 ENPP2 (0.43) ALDH1A1NOTUMHTTTSHRKDM4E
SCHEMBL180853 0.77 ALDH1A1 (0.56) ALDH1A1ALOX15HTTLMNAPOLB
SCHEMBL29365220 0.77 ALDH1A1 (0.56) ALDH1A1ALOX15HTTLMNAPOLB
SCHEMBL4851536 0.76 ALDH1A1 (0.44) ALDH1A1ALOX15NOTUMHTTLMNA
SCHEMBL1662301 0.76 ALDH1A1 (0.52) ALDH1A1ALOX15NOTUMHTTXDH
SCHEMBL27869030 0.76 ALDH1A1 (0.44) ALDH1A1ALOX15NOTUMHTTLMNA
SCHEMBL6913178 0.75 ALDH1A1 (0.54) ALDH1A1ALOX15HTTLMNAPOLB
SCHEMBL6913805 0.75 ALDH1A1 (0.54) ALDH1A1ALOX15HTTLMNAPOLB
Hydrochloric Acid SCHEMBL8901291 0.75 ALDH1A1 (0.54) ALDH1A1ALOX15HTTLMNAPOLB
SCHEMBL6918558 0.75 ALDH1A1 (0.54) ALDH1A1ALOX15HTTLMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016046782-A1 IMIDAZOLE BIARYL COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2016-03-31 WO disclosed